Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women

• Status: Completed
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The present research program is proposed deepening some pharmacological effects of the genistein therapy in order to individualize alternative treatments to the conventional hormonal replacement therapy useful to reduce the cardiovascular morbidity and mortality and the osteoporotic consequences in postmenopausal women.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Messina
• Treatments: Genistein

Criteria

Inclusion Criteria:

• At least one year of menopause

• No use of hormone replacement therapy

• Bone mineral density T-score at the femoral neck minor than one S.D.

Exclusion Criteria:

• Concomitant disease

• Smoke habit